NKA-03

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NameNKA-03
Drug Alias NameNKA-03NKA03
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNKA Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesNKA Bio Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, AdultAcute Lung Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A